Microbot Medical Inc. 8-K

What Happened

• On March 10, 2026 Microbot Medical Inc. (MBOT) filed a Form 8-K (Regulation FD disclosure) to announce it will participate in the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference, held March 16–19, 2026.
• Harel Gadot, the company’s CEO, President & Chairman, is scheduled to present live at 8:40 a.m. ET on Thursday, March 19, 2026.

Key Details

• Filing date: March 10, 2026 (Form 8-K, Item 7.01 disclosure).
• Conference dates: March 16–19, 2026; Microbot presentation: March 19, 2026 at 8:40 a.m. ET.
• Presenter: Harel Gadot — CEO, President & Chairman of Microbot Medical.
• The announcement was issued via press release (furnished with the 8-K).

Why It Matters

• Investor impact: This is a management presentation opportunity where the CEO may discuss strategy, product progress or company developments; such events can influence investor awareness and trading interest.
• No financials: The 8-K does not report earnings, revenue or other financial results — it is a disclosure of the planned presentation only.
• Regulation FD: The filing is a Regulation FD disclosure, meaning the company is publicly sharing information to ensure broad, fair disclosure.